OPEN Health, a global provider of scientific communications and HEOR & market access services, has announced the acquisition of Acsel Health, a New York-based life science strategy and advisory firm focused on commercial strategy, pricing and market access, and commercial excellence.
Acsel's deep industry expertise, scientific rigor, and actionable analysis drives its success in providing valued partnership to life science companies. These capabilities will complement OPEN Health's existing offering, broadening the range of services it offers to pharma and biotech companies.
Lujing Wang, Managing Partner of Acsel Health, said, "We are thrilled to join OPEN Health and to work with a wider team to solve for today's demands and meet tomorrow's expectations for pharma and biotech customers. With new colleagues and capabilities to partner with, we are equipped to answer the most challenging cross-disciplinary questions in life science across all key therapeutic areas."
